|
Volumn 20, Issue 4, 2008, Pages 675-683
|
Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: A MLK-3-MKK7-dependent mechanism
|
Author keywords
ATF 2; Jun N terminal Kinase; MLK 3; p38 MAP Kinase; SB202190; SB203580
|
Indexed keywords
4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE;
ACTIVATING PROTEIN 1;
ACTIVATING TRANSCRIPTION FACTOR 2;
MITOGEN ACTIVATED PROTEIN KINASE KINASE 7;
MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR;
MIXED LINEAGE KINASE 3;
NUCLEIC ACID BINDING PROTEIN;
SB202190;
STRESS ACTIVATED PROTEIN KINASE;
UNCLASSIFIED DRUG;
ARTICLE;
CONTROLLED STUDY;
DOWN REGULATION;
ENDOTHELIUM CELL;
ENZYME ACTIVATION;
ENZYME PHOSPHORYLATION;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN EXPRESSION;
RNA INTERFERENCE;
SIGNAL TRANSDUCTION;
ACTIVATING TRANSCRIPTION FACTOR 2;
CELL LINE, TUMOR;
CELLS, CULTURED;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDOTHELIAL CELLS;
ENZYME ACTIVATION;
ENZYME ACTIVATORS;
HUMANS;
IMIDAZOLES;
JNK MITOGEN-ACTIVATED PROTEIN KINASES;
MAP KINASE KINASE 7;
MAP KINASE KINASE KINASES;
MAP KINASE SIGNALING SYSTEM;
P38 MITOGEN-ACTIVATED PROTEIN KINASES;
PHOSPHORYLATION;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS C-JUN;
PYRIDINES;
RNA INTERFERENCE;
RNA, SMALL INTERFERING;
TRANSCRIPTION FACTOR AP-1;
TRANSFECTION;
|
EID: 39149122494
PISSN: 08986568
EISSN: None
Source Type: Journal
DOI: 10.1016/j.cellsig.2007.12.003 Document Type: Article |
Times cited : (102)
|
References (24)
|